Fibroblast Growth Factor-2-Mediated Protection of Cardiomyocytes From the Toxic Effects of Doxorubicin Requires the mTOR/Nrf-2/HO-1 Pathway

Oncotarget - United States
doi 10.18632/oncotarget.20558

Related search